Bio Green Med Solution Statistics
Total Valuation
BGMS has a market cap or net worth of $5.73 million. The enterprise value is $1.94 million.
| Market Cap | 5.73M |
| Enterprise Value | 1.94M |
Important Dates
The last earnings date was Wednesday, August 12, 2026, after market close.
| Earnings Date | Aug 12, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
BGMS has 6.62 million shares outstanding. The number of shares has increased by 186.01% in one year.
| Current Share Class | 6.62M |
| Shares Outstanding | 6.62M |
| Shares Change (YoY) | +186.01% |
| Shares Change (QoQ) | +2.57% |
| Owned by Insiders (%) | 19.81% |
| Owned by Institutions (%) | 1.54% |
| Float | 5.31M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 3.08 |
| Forward PS | n/a |
| PB Ratio | 0.80 |
| P/TBV Ratio | 1.02 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 1.04 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 8.63
| Current Ratio | 8.63 |
| Quick Ratio | 7.03 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is 34.40% and return on invested capital (ROIC) is -104.37%.
| Return on Equity (ROE) | 34.40% |
| Return on Assets (ROA) | -37.01% |
| Return on Invested Capital (ROIC) | -104.37% |
| Return on Capital Employed (ROCE) | -50.66% |
| Weighted Average Cost of Capital (WACC) | 2.03% |
| Revenue Per Employee | $155,083 |
| Profits Per Employee | -$1.11M |
| Employee Count | 12 |
| Asset Turnover | 0.30 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, BGMS has paid $44,000 in taxes.
| Income Tax | 44,000 |
| Effective Tax Rate | 2.32% |
Stock Price Statistics
The stock price has decreased by -89.17% in the last 52 weeks. The beta is -0.40, so BGMS's price volatility has been lower than the market average.
| Beta (5Y) | -0.40 |
| 52-Week Price Change | -89.17% |
| 50-Day Moving Average | 0.88 |
| 200-Day Moving Average | 1.10 |
| Relative Strength Index (RSI) | 43.72 |
| Average Volume (20 Days) | 26,872 |
Short Selling Information
The latest short interest is 66,628, so 1.01% of the outstanding shares have been sold short.
| Short Interest | 66,628 |
| Short Previous Month | 101,272 |
| Short % of Shares Out | 1.01% |
| Short % of Float | 1.25% |
| Short Ratio (days to cover) | 0.76 |
Income Statement
In the last 12 months, BGMS had revenue of $1.86 million and -$13.32 million in losses. Loss per share was -$2.94.
| Revenue | 1.86M |
| Gross Profit | -451,000 |
| Operating Income | -3.63M |
| Pretax Income | 1.90M |
| Net Income | -13.32M |
| EBITDA | -3.62M |
| EBIT | -3.63M |
| Loss Per Share | -$2.94 |
Balance Sheet
The company has $3.79 million in cash and no debt, with a net cash position of $3.79 million or $0.57 per share.
| Cash & Cash Equivalents | 3.79M |
| Total Debt | n/a |
| Net Cash | 3.79M |
| Net Cash Per Share | $0.57 |
| Equity (Book Value) | 7.16M |
| Book Value Per Share | 1.08 |
| Working Capital | 5.28M |
Cash Flow
In the last 12 months, operating cash flow was -$1.10 million and capital expenditures -$1,000, giving a free cash flow of -$1.10 million.
| Operating Cash Flow | -1.10M |
| Capital Expenditures | -1,000 |
| Depreciation & Amortization | 5,000 |
| Net Borrowing | n/a |
| Free Cash Flow | -1.10M |
| FCF Per Share | -$0.17 |
Margins
Gross margin is -24.23%, with operating and profit margins of -194.95% and -118.27%.
| Gross Margin | -24.23% |
| Operating Margin | -194.95% |
| Pretax Margin | 102.10% |
| Profit Margin | -118.27% |
| EBITDA Margin | -194.68% |
| EBIT Margin | -194.95% |
| FCF Margin | n/a |
Dividends & Yields
BGMS does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -186.01% |
| Shareholder Yield | -186.01% |
| Earnings Yield | -232.40% |
| FCF Yield | -19.16% |
Analyst Forecast
| Price Target | n/a |
| Price Target Difference | n/a |
| Analyst Consensus | n/a |
| Analyst Count | n/a |
| Revenue Growth Forecast (3Y) | 440.69% |
| EPS Growth Forecast (3Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on July 7, 2025. It was a reverse split with a ratio of 1:15.
| Last Split Date | Jul 7, 2025 |
| Split Type | Reverse |
| Split Ratio | 1:15 |
Scores
BGMS has an Altman Z-Score of -74.14 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -74.14 |
| Piotroski F-Score | 4 |